Jeffrey J. Yourick

April 29, 2026

Transcriptomic comparison on the mechanism of action of four major constituent cannabinoids in hemp extract

Abstract Background: A variety of health benefits have been claimed, but not scientifically confirmed, for cannabidiol (CBD) and other nonintoxicating…

April 23, 2025

An updated comparison of microarray and RNA-seq for concentration response transcriptomic study: case studies with two cannabinoids, cannabichromene and cannabinol

Abstract Background: Transcriptomic benchmark concentration (BMC) modeling provides quantitative toxicogenomic information that is increasingly being used in regulatory risk assessment…